VCM
KURA icon

Versant Capital Management’s Kura Oncology KURA Stock Holding History

Versant Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Hold
1,272
– – ﹤0.01% 2109
2026
Q1 		$10.3K Hold
1,272
– – ﹤0.01% 2128
2025
Q4 		$13.2K Hold
1,272
– – ﹤0.01% 1877
2025
Q3 		$11.3K Buy
1,272
+36
+3% +$257 ﹤0.01% 1882
2025
Q2 		$7.13K Buy
1,236
+272
+28% +$1.67K ﹤0.01% 2041
2025
Q1 		$6.36K Buy
+964
New +$7.51K ﹤0.01% 1932

Other funds holding KURA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Versant Capital Management's KURA Position: Q2 2026 in Review

Versant Capital Management held its Kura Oncology (KURA) position steady in Q2 2026 at 1,272 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Versant Capital Management first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. 25 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Versant Capital Management held 1,272 shares of Kura Oncology worth $14K as of Q2 2026.
  • Versant Capital Management left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2109 holding.
  • Versant Capital Management first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • 25 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.